Drug combination might help cure skin cancer, study shows
1st Jun 2015 07:16
Clinical data unveiled on Sunday on occasion of the American Society of Clinical Oncology's annual conference in Chicago showed that a combination of two immunotherapy drugs made by global biopharmaceutical Bristol-Myers Squibb could rise the chances of surviving skin cancer. This combination was fo
Read moreLondon close: Stocks end lower on Greek worries
29th May 2015 17:42
Shares ended the week on a down note, as worries over Greece continued to weigh on investors' minds. Even so, speaking after the close of markets the Mediterranean country's economics minister, Giorgios Stathakis, said Athens will be able to repay the first tranche of its loans to the IMF on 5 June.
Read moreAstrazeneca agrees immuno-oncology collaboration with Eli Lilly
29th May 2015 14:40
UK drug colossus Astrazeneca and US peer Eli Lilly have agreed to collaborate on the hot area of immuno-oncology, where drugs encourage the body's immune system to help battle cancer. The FTSE 100 group, which last month agreed a major collaboration with Celgene, will combine one of its experimental
Read moreFTSE 100 movers: Weir and Associated British Foods surge on upgrades
29th May 2015 12:44
UK stocks shook off early morning caution by the afternoon, making modest gains in spite of Greek debt and panic selling on Chinese markets. As of 14:00 BST, the FTSE 100 was trading 0.04% higher at 7,044. Weir topped the risers as Credit Suisse raised its price target on the stock to 2,205p, citin
Read moreWednesday broker round-up
27th May 2015 07:57
Beazley: JP Morgan upgrades to overweight from neutral and sets 308p target, up from 255p. Hiscox: JP Morgan upgrades to overweight from neutral and ups target to 950p from 801p. Lancashire Holdings: JP Morgan improves target price to 642p from 589p, stays at neutral. Dixons Carphone: Exane keeps
Read moreFTSE 100 movers: Banks and miners weaker, property stocks extend gains
26th May 2015 13:18
UK stocks were were buffeted on Tuesday by Greek uncertainty, stateside interest rate speculation and weakness among miners and financials. As of 14:30 BST, the FTSE 100 was trading 23.5 points lower at 7,008.24. Banking stocks with high eurozone exposure plummeted as Greece concerns merged with Sp
Read moreAstraZeneca shares fall as Amgen ends psoriasis drug deal
26th May 2015 09:54
Shares in drugmaker AstraZeneca fell 1.2%, as investors reacted to news that one of its partners, Amgen, was ending its collaboration to develop psoriasis drug brodalumab, after suicidal thoughts were observed in patients taking it. Amgen and AstraZeneca had been sharing development of the drug sinc
Read moreAstraZeneca to invest £182m to expand drug plant in Sweden
18th May 2015 10:07
Biopharmaceutical giant AstraZeneca has announced it will invest £182m to expand biotech drug manufacturing in Sweden. In a statement released on Monday, the FTSE 100 group said the new facility will be used to supply medicines for clinical trial programmes from the end of 2018, with delivery of fin
Read moreS&P lowers rating on Astrazeneca, says outlook is negative
1st May 2015 16:50
Standard & Poor's has downgraded its rating on Astrazeneca to 'A-1' from 'A-1+', citing a negative outlook amid competition from generic drugmakers. The ratings agency said lost sales to generic competition and significant costs accrued from investments into new drug research and marketing had hurt
Read moreFTSE 100 movers: Astrazeneca hit by rival success, Centrica higher on takeover preparations
28th Apr 2015 13:28
Astrazeneca was trading lower after the results of a study showed US rival Merck's diabetes drug met heart-safety requirements. The British drug-maker's own treatment for the disease was recently required by US authorities to provide information about the risk of heart failure. Standard Chartered wa
Read moreFTSE 100 movers: HSBC rockets on domicile review, Astra hit by heartburn rival
24th Apr 2015 13:19
HSBC topped the risers as it launched a review of its UK domicile in light of the changing regulatory landscape. Some media commentators suggested the announcement, carefully timed ahead of the general election, was politically motivated. After receiving some takeover interest in one of its division
Read moreLondon open: Analysts sanguine on Greece, oil forecasts revised higher
24th Apr 2015 09:17
Stocks have begun the morning moving modestly higher on residual optimism over the Greek debt negotiations and on the coat-tails of overnight gains on Wall Street, which saw the Nasdaq Composite close above its previous early 2000 record highs. "Greece is cash-strapped, and the situation is worsenin
Read moreAstraZeneca earnings fall as generic drugs depress sales, 16% object to board pay
24th Apr 2015 08:11
Drug giant AstraZeneca popped the cap on falling first-quarter sales and earnings but both were at least in line with expectations, while shareholders later gave the board a 'bloody nose' on its director pay policy. Revenues were down 6% to $6.1bn, ahead of consensus City forecasts of $5.7bn, with o
Read moreLondon midday: Bloomberg outage, Chinese regulations send stocks into the red
17th Apr 2015 12:02
After a solid start UK stocks sank into the red by Friday lunchtime, moving further away from recent records amid a blackout on Bloomberg computer terminals and new regulations in China on short-selling. Bloomberg's trading and information units are heavily relied upon by roughly 320,000 people arou
Read moreLondon open: Stocks rise modestly amid Greek talks, UK economic data
17th Apr 2015 08:35
Stocks in London advanced on Friday morning on a quiet day for corporate newsflow, with investors awaiting key employment data from the UK while digesting Greek debt talks. "The FTSE opened the day on the positive side of flat, after yesterday afternoon's [...] declines pulled the index away from it
Read more